MedTrace Logo

Prevention and Early Detection of Cervical Cancer Through Self-Administered Screening

NCT04927650 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 2556

Last updated 2026-05-04

No results posted yet for this study

Summary

This study examines prevention and early detection of cervical cancer through self-administration screening of patients in Western Uganda. The cervix is the opening of the uterus or womb, which is the organ that supports babies before they are born. There are simple tests that let doctors know whether or not patients have cells that may become cancer. Some of the tests determine whether patients have an increased risk for cervical disease, but they do not actually confirm that they have it: these are called "screening" tests. This study may help researchers determine how to best deliver cervical cancer prevention services using the HPV test.

Conditions

  • Cervical Carcinoma
  • Human Papillomavirus-Related Carcinoma

Interventions

DIAGNOSTIC_TEST

HPV testing

Undergo collection of cervical samples for HPV testing

OTHER

Questionnaire Administration

Complete questionnaires

Sponsors & Collaborators

Principal Investigators

  • Jeffrey Martin, MD, MPH · University of California, San Francisco

Eligibility

Min Age
25 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-08
Primary Completion
2027-01-31
Completion
2027-01-31

Countries

  • Uganda

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04927650 on ClinicalTrials.gov